3Haruki T, Nakamura H, Kishimoto S, et al. Squamous cell carcinoma of the lung invaded to esophagus= a case report of successful surgical treatment after preoperative transesophagea[ echographic evaluation[J]. Gen Thorac Cardiovasc Surg,2012, 60(7) ,465-467.
6Sanchez de Cos J, Miravet L, Nunez A, et al. Lung cancer (LC) in Spain: last epidemiological trends concerning age, gender, smoking prevalence and histological types [J].Lung Cancer, 2005,49 (S2) : S196-198.
7Grunnet M, Sorensen JB. Carcinoembryonic antigen(CEA) as tumor marker in lung cancer[J]. Lung Cancer,2012,76(2) :138- 143.
8Matsuguma H, Suzuki H, Ishikawa y, et al. Prognostic value of preoperative serum tumor markers, including CEA, Cyfra21- 1, SCC, CA19-9, SCC, CA125, TPA, NSE, and SLX, in patientswith completely resected pathological stage I non-small cell lungcancer[J]. J Clin Oncol (Meeting Abstracts), 2007,25 (18 Suppl) :7681.
9Homma S, Satoh H, Kagohashi K, et al. Production of CA125 by human lung cancer cell lines[J]. Clin Exp Med,2004,4(3): 139.
10Mizuguchi S, Nishiyama N, Iwata T, et al. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer[J]. Ann Thorac Surg,2007,83(1):216-221.
